Globe Life (GL) valuation
Globe Life P/E ratio history
Globe Life trades at 10.6 times its earnings over the last twelve months and 9.9 times the earnings analysts expect over the next twelve.
n/m: not meaningful (a loss, or earnings close to zero). The daily P/E line is a chart indicator in the app.
Globe Life valuation against its peers
| Company | Market value | P/E | Forward P/E |
|---|---|---|---|
| Globe LifeGL | $12.4B | 10.6 | 9.9 |
| Erie IndemnityERIE | $12.1B | 23.7 | — |
| AssurantAIZ | $14.5B | 14.0 | 12.8 |
| Everest GroupEG | $16.3B | 8.7 | 7.0 |
| LoewsL | $22.9B | 13.7 | — |
| Brown & BrownBRO | $23.3B | 22.4 | 14.8 |
| Principal Financial GroupPFG | $23.9B | 12.4 | 11.2 |
| W. R. BerkleyWRB | $27.5B | 15.2 | 15.2 |
| Cincinnati FinancialCINF | $27.8B | 10.6 | 19.8 |
| Peer median | 13.8 | 13.8 |
Reading these multiples
The P/E divides the share price by earnings per share over the last twelve months; the forward P/E divides it by the earnings analysts expect over the next twelve. Price to sales compares the company's market value with its revenue over the last twelve months. A multiple reads differently from one industry to the next, so the peer group above is the fairer comparison.
See also: GL returns
No forecast, no recommendation. This page describes Globe Life from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.